Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

CD34+ hair follicle stem cells can become melanin-producing cells for treating skin conditions.

TRα and CRABPII genes change their activity levels during goat fetal skin development.

The buffy coat method yields higher TGF-β1 levels in PRP, especially in males.

MMP® with minoxidil may improve hair growth in chronic telogen effluvium.

Mdm2 is crucial for controlling p53 to maintain healthy cells and prevent tumors.

Cavity macrophages gather on organ surfaces but don't really invade or help repair the organs after injury.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

Thuja orientalis extract significantly promotes hair growth in mice with hair loss.

Feeding rats gamma-irradiated flour with pests affects the pests and does not significantly harm the rats.

Testosterone therapy in transgender individuals can increase the risk of erythrocytosis.

StemMACS media is better for growing therapeutic stem cells than PowerStem media.

LED light therapy boosts bone cell growth and function.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

The mouse model is effective for studying ACL graft healing.

Replacing defective mesenchymal cells with normal ones fixes thymic growth issues in 22q11.2DS mouse models.

The study explores miRNA changes in female hair loss.

The study explores miRNA changes in female hair loss.

The package offers tools for exploring potential miRNA changes in female hair loss.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Human and mouse TGase3 enzymes are similar but differ near the activation site, crucial for their function in skin and hair development.

Mutations in specific keratin genes cause improper hair structure in mice due to faulty keratin protein assembly.

Tissue-engineered skin substitutes can model junctional epidermolysis bullosa and may help develop gene therapy.

The plant hormone auxin activates the TOR pathway, affecting gene expression related to growth and cell size.

CE-PTG is a better method for analyzing hair growth in androgenetic alopecia.

FOXN1 gene variants cause low T cells and immune issues from birth.

Meis1 is crucial for skin health and tumor development.

Topical tacrolimus is effective and safe for treating alopecia areata.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.